Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 1/20 | 0.52 |
| ▸ | SELP | P16109 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | LDHA | P00338 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | ALB | P02768 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA7 | P43166 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9482449 | 0.98 | SELL (0.50) | SELLSELPTP53CYP1A2LDHA | |
| SCHEMBL5501258 | 0.98 | SELL (0.50) | SELLSELPTP53CYP1A2LDHA | |
| SCHEMBL31615830 | 0.89 | SELL (0.42) | SELLSELPTP53CYP1A2LDHA | |
| SCHEMBL18585486 | 0.84 | SELL (0.60) | SELLSELPTP53CYP1A2LDHA | |
| SCHEMBL16097553 | 0.82 | SELL (0.64) | SELLSELPTP53CYP1A2LDHA | |
| SCHEMBL625273 | 0.81 | CYP1A2 (0.48) | SELLSELPTP53CYP1A2LDHA | |
| SCHEMBL28219462 | 0.81 | CYP1A2 (0.48) | SELLSELPTP53CYP1A2LDHA | |
| SCHEMBL10874762 | 0.80 | ALDH1A1 (0.34) | SELLSELPTP53ALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL3280994 | 0.79 | CYP1A2 (0.46) | SELLSELPTP53CYP1A2LDHA | |
| SCHEMBL28485577 | 0.79 | CYP1A2 (0.46) | SELLSELPTP53CYP1A2LDHA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3981884-B1 | SINGLE CELL WHOLE GENOME LIBRARIES FOR METHYLATION SEQUENCING | UNIV OREGON HEALTH & SCIENCE (US) | 2023-08-09 | — | — | EP | claimed |
| EP-3635136-B1 | SINGLE CELL WHOLE GENOME LIBRARIES FOR METHYLATION SEQUENCING | UNIV OREGON HEALTH & SCIENCE (US) | 2021-10-20 | — | — | EP | claimed |
| US-20160166507-A1 | NANOEMULSIONS OF HYDROPHOBIC PLATINUM DERIVATIVES | Nemucore Medical Innovations, Inc. (US) | 2016-06-16 | — | — | US | claimed |
| EP-3024441-A1 | NANOEMULSIONS OF HYDROPHOBIC PLATINUM DERIVATIVE | Nemucore Medical Innovations, Inc. (US) | 2016-06-01 | — | — | EP | claimed |
| CN-104749887-A | COMPOSITION FOR FORMING RESIST UNDERLAYER FILM FOR EUV LITHOGRAPHY | NISSAN CHEMICAL IND LTD | 2015-07-01 | — | — | CN | claimed |
| US-9005873-B2 | Composition for forming resist underlayer film for EUV lithography | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-04-14 | — | — | US | claimed |
| WO-2015013566-A1 | NANOEMULSIONS OF HYDROPHOBIC PLATINUM DERIVATIVE | Nemucore Medical Innovations, Inc. (US) | 2015-01-29 | — | — | WO | claimed |
| CN-103787876-A | Synthesis method of medical intermediate 3,5-diiodosalicylic acid | JIANGSU HAOHUA FINE CHEMICAL CO LTD | 2014-05-14 | — | — | CN | claimed |
| US-20140099791-A1 | COMPOSITION FOR FORMING RESIST UNDERLAYER FILM FOR EUV LITHOGRAPHY | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-04-10 | — | — | US | claimed |
| CN-102414619-A | Resist underlayer film forming composition for EUV lithography | NISSAN CHEMICAL IND LTD | 2012-04-11 | — | — | CN | claimed |
| US-20120040291-A1 | COMPOSITION FOR FORMING RESIST UNDERLAYER FILM FOR EUV LITHOGRAPHY | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-02-16 | — | — | US | claimed |
| EP-1344460-A1 | Egg having active oxygen eliminating ability and method of producing same | Nosan Corporation (JP) | 2003-09-17 | — | — | EP | claimed |
| EP-0246978-B1 | REAGENT FOR RENDERING BIOLOGICAL FLUIDS TRANSPARENT AND ITS ANALYTICAL APPLICATIONS | UNIVERSITE DE NANCY I (FR) | 1991-01-09 | — | — | EP | claimed |
| EP-0285025-A2 | Silylated poly(vinyl)phenol resists | SHIPLEY COMPANY INC. (US) | 1988-10-05 | — | — | EP | claimed |
| EP-0246978-A1 | Reagent for rendering biological fluids transparent and its analytical applications | UNIVERSITE DE NANCY I (FR) | 1987-11-25 | — | — | EP | claimed |
| JP-6237798-A | — | — | None | — | — | JP | disclosed |
| EP-4730479-A2 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | Kyoto University (JP) | 2026-04-22 | — | — | EP | disclosed |
| EP-0109051-A2 | Immune complex isolation | Board of Regents of the University of Nebraska (US) | 1984-05-23 | — | — | EP | disclosed |
| US-4410541-A | MONOIODOHIST DINE, FEEDING IODINE COMPOUNDS TO EGG LAYING BIRDS | NIHON NOSAN KOGYO K.K. (JP) | 1983-10-18 | — | — | US | disclosed |
| US-4394376-A | IODINE-ENRICHED EGGS | NIHON NOSAN KOGYO K.K. (JP) | 1983-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160166507-A1 | NANOEMULSIONS OF HYDROPHOBIC PLATINUM DERIVATIVES | MCL1, TUBA3E, HSPE1 | SELL 1156/4885SELP 358/4885TP53 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.